Stock Scorer

Bioharvest Sciences Inc. (BHST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Annual

0 15M 30M 45M FY23: 12.7M FY24: 25.2M FY25: 34.5M FY23 FY24 FY25

Gross Profit Annual

0 7M 14M 21M FY23: 5.6M FY24: 13.9M FY25: 20.5M FY23 FY24 FY25

Operating Income Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY23: -10M FY24: -7M FY25: -5.6M FY23 FY24 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY23: -12.6M FY24: -12.9M FY25: -11.1M FY23 FY24 FY25

Cost of Revenue Annual

0 5M 10M 15M FY23: 7M FY24: 11.2M FY25: 14M FY23 FY24 FY25

Operating Cash Flow Annual

-9M -6M -3M 0 3M 6M 9M FY23: -8.5M FY24: -6.7M FY25: -7.2M FY23 FY24 FY25

Free Cash Flow Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY23: -10M FY24: -9.5M FY25: -9.6M FY23 FY24 FY25

Operating cash flow minus capital expenditure.

EPS Annual

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 FY23: -0.93 FY24: -0.80 FY25: -0.60 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BHST: Shares Outstanding. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.